Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 103.60
-0.80 (-0.77%)
Jun 27, 2025, 4:42 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 509.19 million as of June 27, 2025. Its market cap has increased by 104.15% in one year.
Market Cap
509.19M
Enterprise Value
477.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
103.60
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 509.19M, an increase of 342.63%. That is a compound annual growth rate of 50.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 509.19M | 18.04% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.09B |
| Synektik Spólka Akcyjna | 1.92B |
| Voxel | 1.65B |
| Celon Pharma | 1.18B |
| Ryvu Therapeutics | 732.91M |
| Centrum Medyczne ENEL-MED | 559.95M |
| Selvita | 534.14M |
| EMC Instytut Medyczny | 469.52M |